Tag: HIV
-
HIV Activists Denounce ViiV for Denying 3.5 million People Access to Optimal Treatment
Source : ITPC GLOBAL Today, Monday, 24 July 2017, during the 9th International AIDS Conference on HIV Science in Paris (IAS 2017), HIV treatment activists from around the world collectively blocked access to ViiV Healthcare’s promotional booth and stormed its presentation to physicians. The action, which included taping off ViiV’s booth, to deny access to…
-
ITPC MENA IN THE REGIONAL CONSULTATION ON ACCELERATING ACCESS TO THE CONTIUUM OF HIV CARE: FOCUS ON HIV TESTING
Beirut, Lebanon, 12–14 July 2017 By the end of 2015, the estimated number of people living with HIV in the Region had reached 330 000. With a continuously growing epidemic coupled with low coverage of ART, standing at 14% of people living with HIV, the number of deaths among people living with HIV was 15…
-
New WHO Guidance Report- Treatment Failure and Drug Resistance
WHO urges action against HIV drug resistance threat 20 JULY 2017 | GENEVA – WHO alerts countries to the increasing trend of resistance to HIV drugs detailed in a report based on national surveys conducted in several countries. The Organization warns that this growing threat could undermine global progress in treating and preventing HIV infection if…
-
US Supreme Court Adopts International Exhaustion For Patents: Paving the way for parallel imports to exert downward pressure on domestic pharmaceutical (and other) prices
Source : By Frederick M The Supreme Court of the United States on May 30, 2017 adopted a rule of international exhaustion of patent rights for the United States in Impression Products v. Lexmark International, No. 15-1189. The near-unanimous decision authored by Chief Justice Roberts is unambiguous and unequivocal.[1] The Court paid short shrift to…
-
Access to medicines amendment of the WTO TRIPS Agreement– hype or hope?
By: Ellen ‘t Hoen, Global Health Unit Department of Health Sciences, UMCG Groningen, e.f.m.t.hoen@umcg.nl On 30 January the World Trade Organization (WTO) announced the first ever amendment to the TRIPS Agreement under the headline WTO members welcome entry into force of amendment to ease access to medicines. WTO members were celebrating and some media reported the…
-
M-Coalition launch a new guide: Key Population Engagement in Global Fund Country Dialogue CCMs and the 2017-‐2019 funding cycle
Source : M-Colaition This resource guide is designed to assist civil society organizations in understanding how to access funding from the Global Fund (GF) and effectively engage in country dialogue through all the key stages. In 2014, the Global Fund’s New Funding Model (NFM) was launched. Inclusion of civil society and key affected populations (KAP)…
-
Time is Ticking! Submission Dates for Global Fund Funding Requests
Know your timeline! Submission dates for MENA Global Fund Funding Requests : Greetings from the Regional Communication and Coordination Platform for Middle East & North Africa, hosted by ITPC-MENA. We are preparing a newsletter and series of briefs for you in the coming months, but wanted to make sure you had the following information right…
-
Amendment of the TRIPS Agreement
WTO members on 6 December 2005 approved changes to the WTO’s intellectual property (TRIPS) agreement in order to make permanent a decision on patents and public health originally adopted in 2003. This was formally built into the TRIPS Agreement after acceptance of the Protocol amending the TRIPS Agreement by two thirds of the WTO’s members.…
-
Global Fund Notifies Countries on 2017-2019 Allocations
For the 2017-2019 allocation period, the Global Fund adopted a refined allocation methodology to deliver the aims of its 2017-2022 strategy and to increase the impact of country programs that prevent, treat and care for people affected by HIV, TB and malaria and build resilient and sustainable systems for health. The Global Fund’s 2017-2019 allocation…
-
The Global Fund has a new Sustainability, Transition, and Co-financing Policy
Which means that for the next allocation period, the Global Fund will proactively support sustainability and transition planning, especially for upper middle income countries (UMICs) and low middle income countries (LMICs) with low or moderate disease burdens. Download the new policy, and see below the list of UMICs and LMICs where sustainability and transition planning…